sotorasib,adagrasib,Pembrolizumab
mirati,merck,amgen
[]
 of course, the bar for first line io approvals, even in us, is an os improvement vs. soc in a registrational trial. i think the question is whether these data merit conducting a phase 3, on balance i would say yes.
Lung cancer & Mesothelioma @HopkinsThoracic @HopkinsKimmel Immunotherapy believer. From ????